Objective-An absence of cysteine-rich protein 2 (CRP2) enhances vascular smooth muscle cell (VSMC) migration and increases neointima formation after arterial injury; therefore, CRP2 plays an important role in the response to vascular injury. The goal of the present study was to elucidate the molecular mechanisms that preserve CRP2 expression in the adult vasculature and thus might serve to inhibit the response to injury. Methods and Results-We generated a series of transgenic mice harboring potential Csrp2 regulatory regions with a lacZ reporter. We determined that the 12-kb first intron was necessary for transgene activity in adult but not in developing vasculature. Within the intron we identified a 6.3-kb region that contains 2 CArG boxes. Serum response factor preferentially bound to CArG2 box in gel mobility shift and chromatin immunoprecipitation assays; additionally, serum response factor coactivator myocardin factors activated CRP2 expression via the CArG2 box. Mutational analysis revealed that CArG2 box was important in directing lacZ expression in VSMC of adult vessels.
only CRP family with 2 tandem LIM domains. 1, 2 On the basis of the prominent cytoskeletal association, a cytoarchitectural role has been proposed for CRP proteins 2 and was demonstrated in mice lacking CRP3/muscle LIM protein (MLP). Those mice developed dilated cardiomyopathy with dramatic disruption of cardiomyocyte cytoarchitecture. 3 In addition to a potential cytoarchitectural function, CRP2 also has nuclear functions by strongly enhancing serum response factor (SRF)-mediated smooth muscle (SM) gene expression. 4 CRP2 is strongly expressed in rat carotids 5 and mouse femoral arteries. 6 Importantly, CRP2 levels decrease after balloon or wire artery injury, 5, 6 suggesting an important role for CRP2 in vascular remodeling. Using Csrp2-deficient mice (mouse CRP2 gene symbol), we demonstrated that an absence of CRP2 enhances vascular smooth muscle cell (VSMC) migration and increases neointima formation after arterial injury. 6 In light of the critical role of CRP2 in the response to vascular injury, we sought to elucidate the molecular mechanisms that preserve CRP2 expression in adult blood vessels. Maintaining or upregulating CRP2 expression in adult vessels might blunt VSMC migration and potentially protect against intimal thickening and restenosis. To this end, we recently determined that transforming growth factor-␤ induces CRP2 expression via a cAMP-response promoter element. 7 To identify elements that confer VSMC expression of CRP2 in vivo, we analyzed the Csrp2 promoter using promoter-lacZ reporter gene in transgenic mice. We previously showed that the 5Ј-flanking region between bp-573 and bp 550 that does not contain a CArG box (CC(A/T) 6 GG) is required for lacZ transgene expression in VSMC of the developing vasculature. 8 However, this embryonic module was not able to direct transgene expression in VSMC of blood vessels in adult transgenic mice.
Given that the large intron 1 of SM marker genes SMmajor histocompatability complex 9 and SM ␣-actin 10 are needed for in vivo SMC expression during development and in adults, we hypothesized that the 12-kb first intron of the Csrp2 gene might harbor required elements for adult VSMC expression. The aim of this study was to identify regulatory elements that confer CRP2 expression in VSMC of adult vasculature. Importantly, we show that Csrp2 intron 1 contains 2 CArG boxes and these regulatory sequences are necessary for directing gene expression in adult vasculature.
Materials and Methods
Detailed methods are described in the expanded Materials and Methods section in the Data Supplement (available online at http://atvb.ahajournals.org).
Results

Csrp2 Intron 1 Is Required for LacZ Transgene Expression in VSMC of Adult Blood Vessels
Because CRP2 is highly expressed in adult vasculature 5, 6 and functions, in part, to slow VSMC migration in response to injury, 6 we sought to define the mechanisms that control CRP2 expression in adults. To this end, we examined lacZ expression in adult transgenic mice harboring the longest 5Ј promoter (Ϫ4855Csrp2-lacZ) 11 ( Figure 1A ). LacZ staining of major arteries from 8-week-old Ϫ4855Csrp2 mice revealed very little blue staining in vessels and in medial SMC ( Figure  1B , E, H). Additional transgenic mice harboring 5Ј deletions 8 (Ϫ3513, Ϫ2663, and Ϫ795) exhibited little lacZ expression in adult vessels (data not shown). Because the large intron 1 of SM marker genes SM-major histocompatability complex 9 and SM ␣-actin 10 are required for in vivo SMC expression during development and in adults, we hypothesized that the 12-kb first intron of the Csrp2 gene might harbor required elements for adult VSMC expression. To test this hypothesis, we generated Ϫ825Int1 transgenic mice harboring a Ϫ825-bp promoter that is sufficient for embryonic expression and the first intron upstream of lacZ reporter gene ( Figure 1A) . Compared with promoter-only mice ( Figure 1B ), 8 2 independent founder lines of 8-week-old Ϫ825Int1 mice consistently showed intense reporter activity in great arteries and in the medial SMC but not in endothelial cells of vessels ( Figure  1C , F, I), consistent with endogenous CRP2 expression. 5, 6 Arterial lacZ expressions persisted in 24-week-old mice ( Figure 1D , G, J), indicating intron 1 is important for CRP2 expression in adult vessels.
The ␤-galactosidase activity was also detected in other vascular beds of adult Ϫ825Int1 mice, including arteries in the brain, abdominal vessels, and mesenteric arteries ( Figure  1K -M). Histological analysis revealed blue staining in small arteries ( Figure 1N ) in some but not all coronary arteries ( Figure 1O ) and arterioles ( Figure 1P -Q). In contrast to persistent blue staining in various sizes of arteries in young and adult Ϫ825Int1 mice, lacZ expression in different size vessels of Ϫ4855 mice was diminished in 3-week-old mice and was only weakly detected in adults (Ն6 -8 weeks; Figure 1B and data not shown). Staining of several other Csrp2-expressing tissues 12, 13 of adult Ϫ825Int1 mice revealed strong lacZ activity in bronchial epithelial cells in the lung bronchioles and intestinal epithelial cells in the colon ( Figure 1R -T). LacZ activity was not detected in the kidney ( Figure 1L ), indicating that the promoter-intron fragment recapitulated the endogenous expression of Csrp2 in most tissues.
Two CArG Elements are Present in Intron 1 of the Csrp2 Gene
To identify potential regulatory sites, we cloned and sequenced the mouse Csrp2 intron 1. We identified 2 consensus CArG elements, CArG1 at ϩ5548 (CCTTATTTGG) and CArG2 at ϩ10672 (CCTTTTAAGG) (Figure 2A, B ). Because of the central role of SRF/CArG box interactions in mediating SMC-specific transcription, 14, 15 we performed electrophoretic mobility shift assays to determine whether SRF can bind to these 2 CArG boxes. Incubation of mouse VSMC nuclear extracts with CArG1 probe resulted in a specific DNA-protein complex, which was competed by excess unlabeled identical probe but not by a mutated CArG1 probe ( Figure 2C ). SRF but not unrelated Sp1 antibodies completely supershifted the complex ( Figure 2C ), indicating SRF bound to CArG1 element. A more prominent specific DNA-protein complex was observed when CArG2 probe was used, which was completely supershifted by SRF but not Sp1 antibodies ( Figure 2C ), demonstrating SRF bound to CArG2 box. Chromatin immunoprecipitation assays revealed lowlevel SRF binding to CArG1, whereas SRF binding to CArG2 was substantially higher ( Figure 2D , left). We then performed real-time quantitative polymerase chain reaction to quantify binding levels. Compared with 0.06%Ϯ0.02% binding to CArG1, 0.31%Ϯ0.04% of SRF bound to CArG2 ( Figure 2D , right).
To investigate the function of the CArG-containing region, we cloned the 6.3-kb fragment (bp ϩ5479 to ϩ11752) that contains both CArG boxes upstream of an SV40 promoter to generate pGL2P-6.3 luciferase construct and cotransfected luciferase reporters with a dominant-negative (DN) SRF. In contrast to SRF-independent activity of Ϫ795 promoter, 8 DN-SRF repressed 77% of pGL2P-6.3 activity ( Figure 3A) , indicating the 6.3-kb intronic fragment contained elements responsible for SRF-mediated activity. To determine the role of CArG boxes, we generated mutant constructs with CArG mutations within the context of pGL2P-6.3. Transfection assays revealed that mutation at CArG1 slightly decreased luciferase activity, whereas CArG2 mutation decreased activity to 65%Ϯ3% of wild-type, and double mutation further reduced activity to 55%Ϯ4% ( Figure 3B ). These data suggested that both CArG elements, particularly CArG2, contributed to the transcriptional activity of the 6.3-kb fragment. To further test the role of intron and CArG elements in concert with the native promoter, we generated a luciferase construct Ϫ825Int1-Csrp2-luc, corresponding to the Ϫ825Int1-Csrp2-lacZ transgenic construct, and constructs with CArG mutations. Even in the presence of the 5Јpromoter, 8 mutation of 1 or both CArG boxes dampened luciferase activity ( Figure 3C ), demonstrating the importance of intronic CArG boxes in mediating transcriptional activity of Csrp2.
SRF Coactivators Upregulate Csrp2 Transcription via Intron 1 Sequences in VSMC
As SRF mediates the activity of Csrp2 intron 1 and that SRF coactivators, which include myocardin, myocardin-related transcription factor A (MRTF-A/MKL1), and myocardinrelated transcription factor B (MRTF-B/MKL2), play important roles in regulating transcription of SRF target genes, 16 -19 we hypothesized that SRF coactivators may participate in the regulation of CRP2 expression. C-terminal deletion of the transactivation domain of MRTF-A (DN-A630 and DN-A723) function as DN mutants 18 and are effective in repressing SRF coactivator-induced transactivation of the SM22␣ promoter. 20 Thus, to test our hypothesis, transfection experiments were performed by cotransfecting luciferase constructs with DN-MRTF-A into VSMC. Consistent with previous reports, 20, 21 DN-MRTF-A decreased SM22␣ promoter activity ( Figure  4A) . Interestingly, the repression of Ϫ825Int1 luciferase activity by DN-MRTF-A was similar to that of SM22␣ promoter ( Figure 4A) , indicating a critical role of SRF coactivators in the regulation of CRP2 expression.
We next sought to determine whether myocardin factors mediated Csrp2 induction via intron by transfection experiments. As reported previously, 17, 22 myocardin and MRTF-A activated SM22␣ promoter from 98-fold to 500-fold of pGL2-Basic, whereas MRTF-B activated SM22␣ promoter to 316-fold ( Figure 4B ). Interestingly, myocardin factors had very little activation in Ϫ795 promoter, which was 60-fold of pGL2-Basic ( Figure 4B ), because its transcriptional activity is independent of SRF/CArG box. 8 Importantly, myocardin and MRTF-A increased Ϫ825Int1 activity from 86-fold of pGL2-Basic to 308-fold and 390-fold, respectively, and MRTF-B slightly activated Ϫ825Int1 activity ( Figure 4B) . These data demonstrated that myocardin and MRTF-A are critical in upregulating Csrp2 transcription through intronic sequences. To further identify the elements, we cotransfected Csrp2 reporter pGL2P-6.3 and CArG mutant constructs with expression plasmids into VSMC. Both myocardin and MRTF-A activated pGL2P-6.3 activity 7-fold, whereas MRTF-B activated pGL2P-6.3 activity 3-fold ( Figure 4C) , demonstrating myocardin and MRTF-A, and to a lesser degree MRTF-B, upregulated Csrp2 transcription through intronic sequences. These activations were maintained with CArG1 mutation, whereas mutation of CArG2 alone or both CArG abolished transactivation ( Figure 4C ), suggesting CArG2 played a critical role in mediating the induction of Csrp2 by myocardin factors.
Intronic CArG Elements are Important for LacZ Transgene Expression in VSMC of Adult Vessels
To determine in vivo function of the 2 CArG boxes, we generated CArG1ϩ2mut transgenic mice with both CArG mutated ( Figure 5A ). LacZ staining revealed intense staining of major arteries in E18.5Ϫ825Int1 transgenic embryos ( Figure 5B ). Mutation of CArG did not affect lacZ activity in E18.5 blood vessels ( Figure 5C ), consistent with the notion that CArG is not required for CRP2 expression in the developing vessels. 8, 11 Staining of CArG1ϩ2mut neonates revealed strong lacZ expression in day-1 neonatal vessels (data not shown). Blue staining was maintained at 1 to 2 weeks ( Figure 5D , E). Interestingly, ␤-galactosidase activity was substantially reduced in 3-week-old CArG1ϩ2mut mice ( Figure 5F ), whereas Ϫ825Int1 mice retained high lacZ activity ( Figure 5G ), suggesting that intronic CArG potentially become important around weaning age. Strong lacZ expression was observed in the aorta of 12-week-old Ϫ825Int1 transgenic mice, whereas only faint blue staining was detected in the aorta from 12-week-old CArG1ϩ2mut mice ( Figure 5H , I). Compared with many positive blue nuclei in SM layers of Ϫ825Int1 mouse aorta, few blue SMC were detected in CArG1ϩ2mut aorta ( Figure 5J, K) . To quantitate lacZ expression, we measured aortic ␤-galactosidase activity, which was barely detectable in nontransgenic mice (0.2Ϯ0.1 A 405 /mg protein per hour). Robust activity was detected in Ϫ825Int1 transgenic mouse aorta, whereas mutation of both CArG boxes substantially reduced ␤-galactosidase activity (30.0Ϯ0.9 vs 3.2Ϯ0.3 A 405 /mg protein per hour; Figure 5L ), correlating with the intensity of whole-mount staining results. Together, these data suggest that Csrp2 intronic CArG are required for directing lacZ transgene expression in adult VSMC, but they are dispensable in embryonic vasculature.
CArG2 Is Important for Csrp2 Expression in Adult Blood Vessels
In light of the importance of intronic CArG for VSMC expression in adult vessels ( Figure 5 ), we sought to determine whether a single CArG or both CArG are required. To this end, we generated transgenic mice harboring CArG1 or CArG2 mutation ( Figure 6A ) and then assessed lacZ transgene expression. Mutation of CArG1 retained lacZ activity in the arteries of 12-week-old mice ( Figure 6B ), whereas 2 independent lines of CArG2 mutation showed substantially diminished lacZ staining in the blood vessels ( Figure 6C ). Histological analysis revealed many blue SMC from CArG1 mutant mice ( Figure 6D ), whereas few blue cells were detected in medial layer of CArG2 mutant mice ( Figure 6E ). Together, these data suggest that although CArG1 is dispensable, CArG2 is important for CRP2 expression in VSMC of adult vasculature.
Discussion
Using Csrp2-deficient mice, we have determined a critical role of CRP2 in the response to vascular injury. 6 The goal of the present study was to elucidate the molecular mechanisms that preserve CRP2 expression in the adult vasculature and thus might serve to inhibit the response to injury.
We have shown that the 5Ј-flanking Csrp2 promoter is sufficient to direct reporter gene expression in the developing vasculature and that the promoter activity is not dependent on CArG box or SRF. 8 Of interest, this SRF-CArG-independent regulation was only found in a few SMC-selective genes, including aortic carboxypeptidase-like protein 23 and focal adhesion kinase-related nonkinase. 24 Intriguingly, sequences of a 13-bp fragment (GAAACCCGAAGCC) within the Csrp2 embryonic module were also found in the proximal promoter of aortic carboxypeptidase-like protein, but not focal adhesion kinase-related nonkinase (GenBank accession number NC 000081). Whether these sequences control aortic carboxypeptidase-like protein expression in embryos remains to be determined. However, unlike aortic carboxypeptidase-like protein and focal adhesion kinaserelated nonkinase, we found that lacZ expression was substantially reduced in VSMC of adult vessels in all Csrp2promoter transgenic mice we previously generated 8 (Figure 1 and data not shown), suggesting that in addition to an embryonic control module, a separate adult regulatory module controls CRP2 expression in VSMC of adult vessels. Transgenic studies suggest CArG in the first intron of Csrp2 are the potential adult VSMC regulatory elements for CRP2 expression ( Figure 5 ). However, it is unknown whether the CArG elements are functioning at E18.5 because the proximal promoter of Csrp2 is sufficient to direct reporter gene expression in embryonic vessels. 8 The regulation of Csrp2 expression in VSMC by separate embryonic and adult regulatory modules represents a previously unrecognized distinct mechanism for VSMC gene expression. Interestingly, this mode of regulation is similar to the endothelial cell-specific gene TIE2. 25 The 5Ј-flanking region of the TIE2 promoter is capable of directing transgene expression to vascular endothelial cells of transgenic mouse embryos, whereas a first intron fragment is required for transgene expression in adulthood. 25 The cis-acting element CArG box mediates expression of many SMC marker genes. These SMC-selective CArG boxes are present in 5Ј promoters as for SM22␣ and telokin, 26, 27 in the first intron as for CRP1, 28 or in both 5Ј promoters and first introns as for SM␣-actin and SM-myosin heavy chain. 9, 10, 29 These CArG boxes are needed for SMC expression during embryonic development and in adults. In this regard, the transcriptional regulation of Csrp2 differs from these SMC genes.
Many SM-specific genes contain at least Ն2 CArG boxes in their regulatory regions and function in concert to control SMC-selective expression. 10, 30, 31 Interestingly, there are 2 CArG boxes in the first intron of Csrp2 and both CArG contributed to transcriptional activity in vitro (Figure 3 ). The findings that SRF/CArG regulated Csrp2 transcription are consistent with a previous report that Csrp2 is an SRF target gene. 32 Mutational analysis in transgenic mice (2 lines of CArG2mut and 1 line of CArG1mut) indicated that CArG2 is important for CRP2 expression in adult vessels ( Figure 6 ). Supporting a major functional role for CArG2 instead of CArG1, CArG2 seemed to form a more prominent complex with SRF in electrophoretic mobility shift assays, and SRF preferentially bound to CArG2 in the intact chromatin in chromatin immunoprecipitation assays ( Figure 2C, D) . In line with a critical role of CArG2 in regulating Csrp2 transcription in adult mice, transfection experiments demonstrated that SRF cofactor myocardin and MRTF-A significantly transactivated Csrp2 expression through the CArG2 element ( Figure  4 ). Further supporting the preferential utilization of 1 CArG box in Csrp2 gene regulation, a recent study 33 demonstrated that there is a strong bias for myocardin-dependent transactivation through CArG2 of the CArG box-rich human ACTG2 promoter. Of interest, there are 2 degenerate CArG that exhibit reduced SRF binding affinity in the SM␣-actin promoter, 10 and the degeneracy of the 5Ј CArG is critical for injury-induced SM␣-actin downregulation. 34 Although CArG1 in intron 1 of the Csrp2 gene is not required for CRP2 expression under basal conditions, whether CArG1 plays a role in CRP2 expression in response to vascular injury remains to be determined.
Intriguingly, whereas there appears to be a bias for CArG elements to reside within 4 kb of the transcription start site, 15 the CArG2 of Csrp2 is located 10 kb away from the transcription start site at ϩ10672. Whether these differences are involved in the unique functional regulation of Csrp2 gene transcription requires further investigation. Importantly, although CArG1 does not appear to be conserved across several species examined, CArG2 (CCTTTTAAGG) is highly conserved in CSRP2 gene of humans at ϩ13949, of cows at ϩ12861, and of rhesus monkeys (with a smaller gene size of 8.1 kb) at ϩ1238. A CArG2-like box with 1 base divergence (CCTTTTATGG) is located at ϩ3815 of the 7.7-kb chicken CSRP2 gene, whereas a CArG-like box with 1 base divergent (CCTTTTATGC) from chicken CArG is located at ϩ8789 of the rat Csrp2 gene. Interestingly, we found a ternary complex factor site (GGAA) in the flanking sequences of CArG2 in CSRP2 gene in the species examined. Ternary complex factors have been shown to modulate SMC gene expression via binding to a ternary complex factor site adjacent to the CArG box. 35 Whether a ternary complex factor site and CArG2 coordinately regulate Csrp2 transcription requires further investigation.
Csrp1 and Csrp2 are CRP family members with highly similar gene structure 11, 36 and are expressed in VSMC. 5, 13 However, their mechanisms of expression appear to differ. An intronic CArG box is essential for CRP1 expression in both embryonic and adult vessels, 28 whereas CArG2 box is required for CRP2 expression in adult vasculature (Figures 5,  6 ). Furthermore, although Csrp1 is a target gene of SRF, an expression profiling study identified Csrp1 to be an MRTF-A-independent gene. 37 In contrast, MRTF-A upregulated CRP2 expression ( Figure 4 ).
In this study, although only 1 to 2 independent founder lines of each transgenic construct were analyzed, a total of 6 novel transgenic founder mouse lines were studied (Supplemental Table I and Supplemental Figure I) . Moreover, the transgenic results were consistent with the transfection and chromatin immunoprecipitation results. In conclusion, although CRP2 expression during development is independent of CArG box, its expression in adult VSMC requires CArG2 within intron 1 and might be mediated by myocardin factors. Our results suggest that separate embryonic and adult regulatory modules might control CRP2 expression, which represents a unique mechanism in controlling VSMC gene expression.
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